Sadegh Jafarnejad1, Kurosh Djafarian1, Mohammad Reza Fazeli2, Mir Saeed Yekaninejad3, Abdolrahman Rostamian4, Seyed Ali Keshavarz1. 1. a Department of Clinical Nutrition , School of Nutritional Sciences and Dietetic, Tehran University of Medical Sciences , Tehran , Iran. 2. b Department of Drug & Food Control , Faculty of Pharmacy and Pharmaceutical Quality Assurance Research Centre, Tehran University of Medical Sciences , Tehran , Iran. 3. c Department of Epidemiology , School of Public Health, Tehran University of Medical Sciences , Tehran , Iran. 4. d Department of Rheumatology , Tehran University of Medical Sciences , Tehran , Iran.
Abstract
OBJECTIVE: The development of alternative approaches to prevent and/or treat osteoporosis, as a chronic progressive bone disease, is being considered currently. Among dietary supplements, probiotics may have favorable effects on bone metabolism. Therefore, the aim of this study was to evaluate the effects of a multispecies probiotic supplementation on bone biomarkers and bone density in osteopenic postmenopausal women. METHODS: This randomized double-blind placebo-controlled clinical trial was performed on 50 patients with osteopenia aged 50-72 years. Participants were randomly assigned to take either a multispecies probiotic supplement (GeriLact; n = 25) or placebo (n = 25) for 6 months. GeriLact contains 7 probiotic bacteria species. Participants received 500 mg Ca plus 200 IU vitamin D daily. Bone mineral density (BMD) of lumbar spine and total hip and blood biomarkers including bone-specific alkaline phosphatase (BALP), osteocalcin (OC), collagen type 1 cross-linked C-telopeptide (CTX), deoxypyridinoline (DPD), parathyroid hormone (PTH), 25-OH vitamin D, and serum pro-inflammatory cytokines (tumor necrosis factor [TNF]-α and interleukin [IL]-1β) were assessed at baseline and at the end of the study. RESULTS: The multispecies probiotic significantly decreased BALP (p = 0.03) and CTX (p = 0.04) levels in comparison with the control group but had no effect on BMD of the spine and total hip. Moreover, there was a statistically significant decrease in serum PTH (p = 0.01) and TNF-α (p = 0.02) in the intervention group compared to the placebo group. CONCLUSIONS: These results may suggest the favorable effects of the multispecies probiotic supplementation for 6 months on bone health in postmenopausal women due to slowing down the rate of bone turnover.
RCT Entities:
OBJECTIVE: The development of alternative approaches to prevent and/or treat osteoporosis, as a chronic progressive bone disease, is being considered currently. Among dietary supplements, probiotics may have favorable effects on bone metabolism. Therefore, the aim of this study was to evaluate the effects of a multispecies probiotic supplementation on bone biomarkers and bone density in osteopenic postmenopausal women. METHODS: This randomized double-blind placebo-controlled clinical trial was performed on 50 patients with osteopenia aged 50-72 years. Participants were randomly assigned to take either a multispecies probiotic supplement (GeriLact; n = 25) or placebo (n = 25) for 6 months. GeriLact contains 7 probiotic bacteria species. Participants received 500 mg Ca plus 200 IU vitamin D daily. Bone mineral density (BMD) of lumbar spine and total hip and blood biomarkers including bone-specific alkaline phosphatase (BALP), osteocalcin (OC), collagen type 1 cross-linked C-telopeptide (CTX), deoxypyridinoline (DPD), parathyroid hormone (PTH), 25-OH vitamin D, and serum pro-inflammatory cytokines (tumor necrosis factor [TNF]-α and interleukin [IL]-1β) were assessed at baseline and at the end of the study. RESULTS: The multispecies probiotic significantly decreased BALP (p = 0.03) and CTX (p = 0.04) levels in comparison with the control group but had no effect on BMD of the spine and total hip. Moreover, there was a statistically significant decrease in serum PTH (p = 0.01) and TNF-α (p = 0.02) in the intervention group compared to the placebo group. CONCLUSIONS: These results may suggest the favorable effects of the multispecies probiotic supplementation for 6 months on bone health in postmenopausal women due to slowing down the rate of bone turnover.
Entities:
Keywords:
Probiotic; bone biomarkers; osteopenia; osteoporosis; postmenopausal women; pro-inflammatory cytokines
Authors: Naiomy Deliz Rios-Arce; Jonathan D Schepper; Andrew Dagenais; Laura Schaefer; Connor S Daly-Seiler; Joseph D Gardinier; Robert A Britton; Laura R McCabe; Narayanan Parameswaran Journal: Bone Date: 2020-02-21 Impact factor: 4.398
Authors: Jonathan D Schepper; Regina Irwin; Jun Kang; Kevin Dagenais; Tristan Lemon; Ally Shinouskis; Narayanan Parameswaran; Laura R McCabe Journal: Adv Exp Med Biol Date: 2017 Impact factor: 2.622
Authors: Nicole C Aurigemma; Kristen J Koltun; Hannah VanEvery; Connie J Rogers; Mary Jane De Souza Journal: Curr Osteoporos Rep Date: 2018-02 Impact factor: 5.096